[HTML][HTML] Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients

BM Luis, MB Miguel, DL Pedro, IP David, A Itziar… - Journal of translational …, 2021 - Elsevier
… are key features in the pathophysiology of COVID-19. Apart from antivirals and respiratory
support, anticoagulants, corticoids and immunomodulators are increasingly being prescribed, …

The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy

HY Lin - Chinese Journal of Traumatology, 2020 - mednexus.org
… The researches of immunomodulatory therapy in sepsis have been going … -COVID-19
guideline.35 In China, there is also no specific item of immunomodulatory therapy in the COVID-19

Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics

P Yadav, R Vats, A Bano, R Bhardwaj - Life Sciences, 2020 - Elsevier
… to be an alternative promising therapy for COVID-19. In this review … immunomodulatory
and regenerative therapeutic potential of mesenchymal stem cells for the treatment of COVID -19

Combining antivirals and immunomodulators to fight COVID-19

V Feuillet, B Canard, A Trautmann - Trends in immunology, 2021 - cell.com
… response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV… COVID-19
is essential when aiming to purposely combine antivirals with the use of an immunomodulator

The effects of systemic immunomodulatory treatments on COVID19 outcomes in patients with atopic dermatitis: results from the global SECURE‐AD registry

AH Musters, C Broderick… - Journal of the …, 2023 - Wiley Online Library
immunomodulatory therapies on COVID-19therapy only or a single systemic therapy for
AD (ie systemic monotherapy) were analysed separately to those receiving systemic therapies

Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19

VJ Venditto, D Haydar, A Abdel-Latif… - Frontiers in …, 2021 - frontiersin.org
… The rapid advancement of the COVID-19 pandemic has … Many immunomodulatory therapies
for COVID-19 are currently … Azithromycin is an immunomodulatory drug that has been …

Immunomodulatory therapies for COVID-19

M Poonam, S Kottilil - Frontiers in Medicine, 2022 - archive.hshsl.umaryland.edu
COVID-19 patients. In this review, we will explore the evidence that has accumulated from
the use of immunomodulating therapies for COVID-19 … the IDSA guidelines for COVID-19 (4): …

COVID19 and immunological regulations–from basic and translational aspects to clinical implications

MP Schön, C Berking, T Biedermann… - JDDG: Journal der …, 2020 - Wiley Online Library
immunomodulatory therapies on COVID-19. In COVID-19 patients treated with immunomodulatory
… For example, immunomodulators could influence cytokine formation and action, virus …

[HTML][HTML] Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy

HSC Wong, CL Guo, GH Lin, KY Lee, Y Okada… - Genomics, 2021 - Elsevier
… The recent outbreak of coronavirus disease 2019 (COVID-19… available medications for
COVID-19 therapy. Eight of them … 2 infection and thus to be repositioned for COVID-19 therapy. …

Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent, M Rosa-Calatrava… - Current Opinion in …, 2022 - Elsevier
immunomodulators and drug combinations that could be used in the near future to cure
COVID-19… Strong (severe COVID-19) Antiviral therapy needs to be administrated at the right time. …